Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083
Published February 9, 2022 · Recall initiated: December 21, 2021
Summary
FDA records drug Class II recall D-0463-2022, published February 9, 2022 and initiated December 21, 2021. Recalling firm: Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy; Status: Ongoing; Reported quantity: 57,994 vials; Lot: All lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy
- Distributor
- nationwide in the USA
- Lot
- All lots within expiry
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADoxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, RxFebruary 9, 2022
- FDANasal & Sinus Decongestant (phenylephrine HCl 5mg) 2 tablets per packet, Mfd. for Cintas First Aid & Safety,February 9, 2022
- FDACold Tablet Pain Reliever/Fever Reducer/Expectorant/Nasal Decongestant (acetaminophen 325 mg, GuaifenesinFebruary 9, 2022
- FDAAERO TAB Cold Relief (acetaminophen 325 mg, Guaifenesin 200mg, Phenylephrine HCl 5mg) 2 tablet packets, Mfg.February 9, 2022
- FDAGE Vscan Extend, being sold as "Vscan Extend Sector DICOM"February 2, 2022
- FDAGE Vscan Extend, being sold as "Vscan Extend Dual Wi-Fi"February 2, 2022
Questions about this recall
Was Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single Dose Vial, RX Only, Ideal Pharmacy, 2333 Morris Ave, Union, NJ 07083 recalled?
Yes. FDA published recall D-0463-2022 on February 9, 2022. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter